Dose enlargement stage with the review: topics needs to have relapsed/refractory RMS or even a stable malignant tumor (Ewing sarcoma, hepatoblastoma, neuroblastoma and Wilms tumor) in which treatment with vincristine/irinotecan is considered backbone chemotherapy at relapse as well as a scientific rationale to mix vincristine/irinotecan with regorafenib exists. We regard https://stevep258zfk8.glifeblog.com/profile